# Nuveen Churchill Direct Lending Corp.: overview NCDL · NYSE · CIK 1737924 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ncdl.md) · [Financials](/companies/ncdl/financials.md) · [Filings](/companies/ncdl/filings.md) · [Insiders](/companies/ncdl/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.58](/filings/0001737924-25-000013.md) | not reported | [0.53](/filings/0001628280-25-023397.md) | [0.46](/filings/0001628280-25-038050.md) | [0.43](/filings/0001737924-25-000013.md) | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.58](/filings/0001628280-24-007039.md) | [1.95](/filings/0001628280-25-008382.md) | [2.52](/filings/0001737924-26-000014.md) | [2.26](/filings/0001737924-26-000014.md) | [1.86](/filings/0001737924-26-000014.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ncdl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Blue Owl Capital Holdings LP](/funds/1858703.md) | 2026-06-30 | $26.6m | 2,143,626 | | Unchanged | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $20.0m | 1,613,098 | | Reduced −119,521 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $12.4m | 997,794 | | Added +315,661 | | [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $11.9m | 958,826 | | Added +383,988 | | [BROWN BROTHERS HARRIMAN & CO](/funds/14661.md) | 2026-06-30 | $11.5m | 921,978 | | Unchanged | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $11.1m | 893,252 | | Reduced −285 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $9.5m | 767,952 | | Added +254,335 | | [Opal Wealth Advisors, LLC](/funds/1844201.md) | 2026-06-30 | $7.9m | 634,271 | | Added +9,056 | | [Diameter Capital Partners LP](/funds/1727012.md) | 2026-06-30 | $7.5m | 604,645 | | Reduced −774,716 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $6.9m | 552,184 | | Reduced −78,563 | ## Recent filings [All 355 filings](/companies/ncdl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 07:22 ET | [8-K](/filings/0001737924-26-000086.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001737924-26-000086 | | 2026-08-06 | 21:28 ET | [10-Q](/filings/0001737924-26-000084.md) | Quarterly report, period 2026-06-30 | 0001737924-26-000084 | | 2026-07-10 | 16:30 ET | [8-K](/filings/0001737924-26-000079.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001737924-26-000079 | | 2026-05-28 | 13:32 ET | [8-K](/filings/0001737924-26-000052.md) | 5.07 Shareholder vote results | 0001737924-26-000052 | | 2026-05-07 | 07:17 ET | [8-K](/filings/0001737924-26-000048.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001737924-26-000048 | | 2026-05-07 | 21:12 ET | [10-Q](/filings/0001737924-26-000045.md) | Quarterly report, period 2026-03-31 | 0001737924-26-000045 | | 2026-04-07 | 17:46 ET | [DEF 14A](/filings/0001737924-26-000034.md) | Proxy statement, period 2026-05-21 | 0001737924-26-000034 | | 2026-03-20 | 09:21 ET | [8-K](/filings/0001737924-26-000023.md) | 8.01 Other events | 0001737924-26-000023 | | 2026-02-26 | 07:22 ET | [8-K](/filings/0001737924-26-000016.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001737924-26-000016 | | 2026-02-26 | 21:57 ET | [10-K](/filings/0001737924-26-000014.md) | Annual report, period 2025-12-31 | 0001737924-26-000014 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001737924-26-000014.md), filed Feb 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1737924 - Tickers: NCDL - Exchange: NYSE - SIC code: not reported - State of incorporation: MD - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.